Dual-chamber defibrillators reduce clinically significant adverse events compared with single-chamber devices: Results from the DATAS (Dual chamber and Atrial Tachyarrhythmias Adverse events Study) trial

  1. Almendral, J.
  2. Arribas, F.
  3. Wolpert, C.
  4. Ricci, R.
  5. Adragao, P.
  6. Cobo, E.
  7. Navarro, X.
  8. Quesada, A.
Journal:
Europace

ISSN: 1099-5129 1532-2092

Year of publication: 2008

Volume: 10

Issue: 5

Pages: 528-535

Type: Article

DOI: 10.1093/EUROPACE/EUN072 GOOGLE SCHOLAR